Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Icl Group Ltd (ICL) vs Morgan Stanley (MS) Price & Performance

Icl Group LtdTrade
Morgan StanleyTrade

Price performance (Past 24H)

Key statistics

Icl Group Ltd vs Morgan Stanley — how do they compare? Icl Group Ltd trades at $5.27 (market cap $6.65B), while Morgan Stanley trades at $215.9 (market cap $331.60B). The key difference: Morgan Stanley is far larger — about 49.9× Icl Group Ltd's market cap, and Icl Group Ltd pays the higher dividend (3.77%). Which is the better fit depends on your goals.

ICLMS
Market Cap
$6.65B$331.60B
Sector
Basic MaterialsFinancials
52-Week High
$7.03$228.42
52-Week Low
$4.80$139.09
Enterprise Value
$9.22B
Dividend Yield
3.77%2.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Icl Group Ltd

ICL trades at $5.00, down 0.99% over 24 hours, with a bearish technical signal. The company reported Q1 2026 earnings of $0.11 per share, beating estimates, and recently completed an $800 million senior notes offering. Revenue for 2025 was $7.15 billion with a net income margin of 3.15%, while valuation ratios show a P/E of 24.05 and P/S of 0.88. Analyst consensus is entirely hold-rated, reflecting cautious sentiment amid mixed financial trends.

The outlook for ICL is neutral with modest growth potential, supported by operational improvements and raised 2026 EBITDA guidance. Key risks include elevated raw material costs, foreign exchange headwinds, and competitive pressures in the specialty minerals sector. Investors should weigh stable cash flows against margin compression and debt levels from recent financing activities.

Morgan Stanley

Morgan Stanley (MS) trades at $215.48, down 1.33% on the day, with a bullish technical signal and strong fundamental performance. Revenue grew to $66.0B in 2025, with net income reaching $16.9B and a profit margin of 25.6%. The stock has beaten earnings estimates for three consecutive quarters, and analysts maintain a consensus buy rating with a $241.36 price target. Recent news highlights Morgan Stanley's role in leading Anthropic's IPO and expanding AI integration in wealth management.

The outlook for MS is positive, driven by earnings momentum and strategic initiatives like AI adoption and high-profile IPOs. Risks include volatile cash flows from operations and rising debt-to-asset ratios. The stock offers potential upside to the consensus target, but investors should monitor execution on growth initiatives and macroeconomic impacts on financial services.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Icl Group Ltd

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.

Read more on ICL

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS